How long-acting risperidone works in the body and its treatment benefits from combining a newer antipsychotic with a new delivery method
Updated
Abstract
Long-acting risperidone can be administered once every 2 weeks, providing sustained therapeutic plasma levels.
- Long-acting antipsychotic preparations are associated with improved compliance and relapse prevention compared to oral agents.
- Partial or non-compliance remains a significant issue with oral atypical antipsychotic agents.
- The long-acting formulation of risperidone may enhance symptom control and quality of life for patients already stable on other treatments.
- The use of microsphere technology in drug delivery supports sustained medication levels in the bloodstream.
Simplified